Company Lookup
Download Demo

Market News

This Month News

This Month News

send to a friend by email

JPH posts net income of $2.90 million in 9M 2015


According to the financial statements of Jerusalem Pharmaceuticals Company JPH for the first nine months of 2015, Net profit after tax of the period reached 2,896,369 USD Compared with Net profit after tax 1,033,909 USD for 2014, a net increase in profit of 180.14%.Total assets of the company reached 55,370,176 USD compared with total assets of 53,002,542 USD at the end of year 2014, a net increase of 4.47%.Total liabilities of the company reached 17,572,735 USD compared with total liabilities of 18,425,325 USD at the end of year 2014, a net decrease of 4.62%. Net ownership equity of the company reached 37,797,441 USD (Including Non-Controlling Interests of 2,200,836 USD) compared with total owner equity of 34,577,217 USD (Including Non-Controlling Interests of 426,164 USD) at the end of year 2014, a net increase of 9.31%.


PID posts net income of JD0.65 million in 9M 2021

NAPCO posts net income of JD0.34 million in 9M 2021

RSR posts net income of JD0.31 million in 9M 2021

APC records net income of JD0.82 million in 9M 2021

ARAB posts net income of JD0.02 million in 9M 2021

Al-Quds Index in a narrow range amid an increase in 9M financial data disclosures anticipation

PHARMACARE recommends distributing 10% cash dividends for the year 2020

A transaction on the stocks of TRSUT raises the trading value in the PEX

Al-Quds Index rebounds upwards in the first week of October



Sahem Trading & Investments Company - PEX Member and licensed by PCMA
© All Rights Reserved 2013